Company news

Kamada Ltd. news in 2022

Kamada Ltd.'s news releases, calls and decks from 2022, newest first.

View company

Kamada Announces Planned Transition of Chief Financial Officer

December 18, 2022

Kamada Reports Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance

November 21, 2022

Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2022 Financial Results and Host Conference Call on November 22, 2022

November 15, 2022

Kamada Provides Update on Recent Progress Achieved in Ongoing Pivotal Phase 3 Clinical Trial of Inhaled AAT

November 6, 2022

Kamada to Present at the Credit Suisse 31st Annual Healthcare Conference

October 25, 2022

Kamada Awarded $22 Million Extension of Canadian Supply Tender

October 18, 2022

Kamada Reports Second Quarter and First Half 2022 Financial Results; Significant Growth Driven by Multiple Catalysts Expected in Second Half of 2022; Reiterates 2022 Revenue and Profitability Guidance

August 16, 2022

Kamada to Announce Second Quarter and First Half Ended June 30, 2022 Financial Results and Host Conference Call on August 17, 2022

August 9, 2022

Kamada Announces Resolution to the Labor Strike at the Company’s Manufacturing Facility in Israel; A New, Eight-Year Collective Agreement Signed

July 14, 2022

Kamada Announces $11.4 Million International VARIZIG® Procurement Agreement

July 5, 2022

Kamada Strengthens Senior Leadership Team; Furthering Commitment as a Fully Integrated Global Leader in the Specialty Plasma-Derived Therapeutics Market

June 14, 2022

Kamada to Host a Virtual Analysts and Investors Meeting to Review its Growth Catalysts

May 31, 2022

Kamada Reports First Quarter 2022 Financial Results; Reiterates Revenue and Profitability Guidance with Significant Growth Expected in 2022

May 16, 2022

Kamada Announces Expansion of Pivotal Phase 3 Clinical Trial of Inhaled AAT to Additional Six Clinical Sites Across Europe; and Positive Recommendation by DSMB to Continue the Trial Without Modification

May 16, 2022

Kamada to Announce First Quarter Ended March 31, 2022 Financial Results and Host Conference Call on May 17, 2022

May 10, 2022

Kamada Reports Fiscal Year and Fourth Quarter 2021 Financial Results; Provides Revenue and Profitability Guidance with Significant Growth Expected in 2022

March 14, 2022

Kamada Issues 2022 CEO Letter to Shareholders

March 14, 2022

Kamada Expands U.S. Leadership Team with Two Key Appointments

March 13, 2022

Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2021 Financial Results, and Host Conference Call on March 15, 2022

March 1, 2022

Calls in 2022